Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

379 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe.
Barkholt L, Bregni M, Remberger M, Blaise D, Peccatori J, Massenkeil G, Pedrazzoli P, Zambelli A, Bay JO, Francois S, Martino R, Bengala C, Brune M, Lenhoff S, Porcellini A, Falda M, Siena S, Demirer T, Niederwieser D, Ringdén O; French ITAC group and the EBMT Solid Tumour Working Party. Barkholt L, et al. Among authors: bay jo. Ann Oncol. 2006 Jul;17(7):1134-40. doi: 10.1093/annonc/mdl086. Epub 2006 Apr 28. Ann Oncol. 2006. PMID: 16648196 Free article. Clinical Trial.
Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma.
Crocchiolo R, Ringden O, Bay JO, Blaise D, Omasic B, Mazzi B, Picard C, Trinca S, Barkholt L, Peccatori J, Gregori S, Amodio G, Fleischhauer K, Ciceri F, Bregni M. Crocchiolo R, et al. Among authors: bay jo. Bone Marrow Transplant. 2018 Feb;53(2):213-218. doi: 10.1038/bmt.2017.243. Epub 2017 Nov 13. Bone Marrow Transplant. 2018. PMID: 29131154
Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Detrait MY, Morisset S, Peffault de Latour R, Yakoub-Agha I, Crocchiolo R, Tabrizi R, Bay JO, Chevalier P, Barraco F, Raus N, Vigouroux S, Magro L, Mohty M, Milpied N, Blaise D, Socié G, Michallet M. Detrait MY, et al. Among authors: bay jo. Bone Marrow Transplant. 2015 Feb;50(2):253-8. doi: 10.1038/bmt.2014.244. Epub 2014 Nov 3. Bone Marrow Transplant. 2015. PMID: 25365068
HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM.
Robin M, Porcher R, Adès L, Raffoux E, Michallet M, François S, Cahn JY, Delmer A, Wattel E, Vigouroux S, Bay JO, Cornillon J, Huynh A, Nguyen S, Rubio MT, Vincent L, Maillard N, Charbonnier A, de Latour RP, Reman O, Dombret H, Fenaux P, Socié G. Robin M, et al. Among authors: bay jo. Leukemia. 2015 Jul;29(7):1496-501. doi: 10.1038/leu.2015.37. Epub 2015 Feb 13. Leukemia. 2015. PMID: 25676424
[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2)].
Nguyen S, Blaise D, Bay JO, Chevallier P, Contentin N, Dhédin N, Duléry R, Eliaou JF, Rubio MT, Suarez F, Bulabois CE, Cornillon J, Huynh A, Magro L, Michallet M, Paillard C, Turlure P, Yakoub-Agha I; SFGM-TC. Nguyen S, et al. Among authors: bay jo. Pathol Biol (Paris). 2014 Aug;62(4):185-9. doi: 10.1016/j.patbio.2014.05.002. Epub 2014 Jun 18. Pathol Biol (Paris). 2014. PMID: 24954121 French.
[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (Part 1)].
Blaise D, Nguyen S, Bay JO, Chevallier P, Contentin N, Dhédin N, Duléry R, Eliaou JF, Rubio MT, Suarez F, Bulabois CE, Cornillon J, Huynh A, Magro L, Michallet M, Paillard C, Turlure P, Yakoub-Agha I; SFGM-TC. Blaise D, et al. Among authors: bay jo. Pathol Biol (Paris). 2014 Aug;62(4):180-4. doi: 10.1016/j.patbio.2014.05.004. Epub 2014 Jun 25. Pathol Biol (Paris). 2014. PMID: 24973859 French.
Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Chevallier P, Labopin M, Milpied N, Bilger K, Socié G, Yakoub-Agha I, Michallet M, Bulabois CE, Maury S, Beguin Y, Bay JO, Blaise D, Maillard N, Guillerm G, Daguindeau E, Raus N, Mohty M. Chevallier P, et al. Among authors: bay jo. Bone Marrow Transplant. 2014 Mar;49(3):361-5. doi: 10.1038/bmt.2013.186. Epub 2013 Dec 2. Bone Marrow Transplant. 2014. PMID: 24292522
Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord.
Nguyen S, Achour A, Souchet L, Vigouroux S, Chevallier P, Furst S, Sirvent A, Bay JO, Socié G, Ceballos P, Huynh A, Cornillon J, Francois S, Legrand F, Yakoub-Agha I, Michel G, Maillard N, Margueritte G, Maury S, Uzunov M, Bulabois CE, Michallet M, Clement L, Dauriac C, Bilger K, Lejeune J, Béziat V, Rocha V, Rio B, Chevret S, Vieillard V. Nguyen S, et al. Among authors: bay jo. Bone Marrow Transplant. 2017 Oct;52(10):1428-1435. doi: 10.1038/bmt.2017.122. Epub 2017 Jun 26. Bone Marrow Transplant. 2017. PMID: 28650455 Clinical Trial.
379 results